SCHEMBL24718424

SCHEMBL24718424

O=C(NC1CC(=O)N(Cc2ccccc2C(F)(F)F)C1)c1cc(Cl)nc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.52
▸ GAA P10253 3/20 0.52
▸ RAB9A P51151 2/20 0.50
▸ P2RX7 Q99572 1/20 0.43
▸ RIPK1 Q13546 1/20 0.43
▸ TP53 P04637 2/20 0.43
▸ ACACB O00763 1/20 0.43
▸ ACACA Q13085 1/20 0.43
▸ USP2 O75604 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ MAPT P10636 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24718426 0.84 SLC6A12 (0.49) KMT2AGAAP2RX7RIPK1TP53
SCHEMBL24718827 0.81 TP53 (0.49) KMT2AGAAP2RX7RIPK1TP53
SCHEMBL24718398 0.81 TP53 (0.44) KMT2AP2RX7RIPK1TP53MEN1
SCHEMBL24718419 0.80 TP53 (0.45) KMT2AGAAP2RX7RIPK1TP53
SCHEMBL24719134 0.80 NPC1 (0.47) KMT2AGAARAB9AP2RX7RIPK1
SCHEMBL24718304 0.80 TP53 (0.47) KMT2AGAAP2RX7RIPK1TP53
SCHEMBL24718637 0.80 TP53 (0.49) KMT2AGAARAB9AP2RX7RIPK1
SCHEMBL24718839 0.80 TP53 (0.49) KMT2AGAAP2RX7RIPK1TP53
SCHEMBL24718825 0.79 SCN9A (0.49) GAAP2RX7TP53MAPTALDH1A1
SCHEMBL24718659 0.79 MEN1 (0.46) KMT2AGAAP2RX7RIPK1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 KMT2A 180/4885GAA 4271/4885RAB9A 1239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback